FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1684 June 5, 1997 Number 23

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Ronald A. Asherson, Ricard Cervera, Jean-Charles Piette, and Yehuda Shoenfeld. 339 pp., illustrated. Boca Raton, Fla., CRC Press, 1996. $149.95. ISBN 0-8493-9423-6.

The antiphospholipid-antibody syndrome is enigmatic for several reasons. Until recently, there was no standardized definition of the syndrome. The associated antibodies (lupus anticoagulant and anticardiolipin antibody) can come and go in a given patient, and experts differ about which tests should be performed. It is clear that the antibodies are associated with clinical complications such as thromboembolism, thrombocytopenia, and loss of pregnancy, but it is unclear whether the antibodies actually cause these complications. Most daunting for clinicians is the paucity of controlled clinical trials of treatments for the syndrome.

The editors have assembled a group of internationally recognized authors, who . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.